|
Mar 11
|
1 Healthcare Stock to Target This Week and 2 to Turn Down
|
|
Mar 11
|
Winners And Losers Of Q4: Myriad Genetics (NASDAQ:MYGN) Vs The Rest Of The Therapeutics Stocks
|
|
Mar 10
|
4 Discounted PEG Stocks Offering the Best Returns to Value Investors
|
|
Feb 24
|
Oppenheimer upgrades BioMarin on long term outlook
|
|
Feb 24
|
Does BioMarin (BMRN) Have the Potential to Rally 40.54% as Wall Street Analysts Expect?
|
|
Feb 24
|
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
|
|
Feb 24
|
Alibaba upgraded, Rivian downgraded: Wall Street's top analyst calls
|
|
Feb 21
|
BioMarin price target raised to $80 from $78 at Scotiabank
|
|
Feb 21
|
BioMarin Pharmaceutical Full Year 2024 Earnings: Beats Expectations
|
|
Feb 21
|
Pfizer stops selling hemophilia gene therapy, citing weak demand
|
|
Feb 20
|
Why BioMarin Pharmaceutical Stock Zoomed Almost 5% Higher Today
|
|
Feb 20
|
Why BioMarin Pharmaceutical (BMRN) Stock Is Trading Up Today
|
|
Feb 20
|
Why Is BioMarin Stock Trading Higher On Thursday?
|
|
Feb 20
|
BioMarin Q4 Earnings & Sales Top Estimates, Stock Up on Upbeat '25 View
|
|
Feb 20
|
Q4 2024 BioMarin Pharmaceutical Inc Earnings Call
|
|
Feb 20
|
Biomarin Pharmaceutical Inc (BMRN) Q4 2024 Earnings Call Highlights: Record Growth and ...
|
|
Feb 19
|
Compared to Estimates, BioMarin (BMRN) Q4 Earnings: A Look at Key Metrics
|
|
Feb 19
|
BioMarin Pharmaceutical (BMRN) Surpasses Q4 Earnings and Revenue Estimates
|
|
Feb 19
|
BioMarin: Q4 Earnings Snapshot
|
|
Feb 19
|
BioMarin Pharmaceutical (NASDAQ:BMRN) Reports Bullish Q4, Stock Soars
|